Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
Advertisement
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
Life & Times

COVID-19 and the creation of a new disease

James Hibberd
British Journal of General Practice 2020; 70 (697): 401. DOI: https://doi.org/10.3399/bjgp20X712013
James Hibberd
Islington, North London. Email:
Roles: GP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: james.hibberd@nhs.net
  • Article
  • Info
  • eLetters
  • PDF
Loading

Disease is more than purely biological. Chemical imbalances, hormone deficiencies, and micro-organisms are filtered through the human experience to create the phenomenon we call a disease. As Charles Rosenberg wrote in his essays on this subject: ‘In some ways disease does not exist until we have agreed that it does, by perceiving, naming, and responding to it.’1

Rosenberg argued that patients, families, clinicians, charities, hospitals, professional bodies, insurers, employers, the media, and the government all frame biology in a way that both makes sense to and benefits them.

Working for the last couple of months as a GP in one of the ‘hot hubs’ in North London, Rosenberg’s words resonated with me as I watched the emergence of a new disease in exactly the way that he predicted. COVID-19 was framed by the experiences of patients and doctors and the interplay between the media and the changing policies from the NHS and government. What was also apparent was that the frame was shifting from week to week.

In the early weeks of the crisis I was working in the overwhelmed 111 setting.2 The government was concentrating on protecting the NHS and the messaging was focused on staying at home. The primary care concern was on how to triage safely3 and manage as many people at home as possible. The doctors working on the phones framed the disease as an acute illness. Once a patient had passed week 2 the danger was felt to be over and hospitalisation unlikely.

COVID-19 IS A CHRONIC ILLNESS

After a couple of weeks in the hot hub the frame shifted. The first pulmonary emboli4 and fibrotic lung changes5 began to be seen weeks after the initial illness. The respiratory teams at the local hospitals became involved and took ownership. Clinics were set up and the disease became re-framed as a chronic respiratory issue. We saw a corresponding spike in referrals to the hot hub with chest pain and breathlessness coupled with a similar spike of referrals from us into the hospital. Only two of the patients we referred had thrombotic disease; neither was felt to be COVID-19 related.

Then there was the news in the press6 as well as an emailed alert to all GPs7 highlighting the small number of children suffering from a Kawasaki-like illness.8 In the minds of both the public and of GPs the disease frame shifted again, from being a disease of older people to be a potentially life-threatening childhood illness. We saw a corresponding spike of referrals both to the hub and to A&E; no significant COVID-19 illnesses were diagnosed.

More recently, patients began presenting with severe fatigue weeks after the initial infection and persisting in some cases for over 2 months. Little mentioned in the literature, this has been widely reported by patients. Online support groups have been set up to both help with the symptoms and gather data.9 Recognition of this has led to another shift towards GPs and patients framing COVID-19 as a chronic illness.

The reality is that COVID remains most dangerous in the early stages, as was initially shown in the data from China.10 It is also more hazardous to people with certain characteristics.11 As has happened throughout the history of medicine, the disease that is being created in the minds of some patients and doctors sometimes seems to bear little relationship to these biological facts.

DEFINING THIS NEW DISEASE

We must recognise that as clinicians we are involved in creating a new disease. According to Rosenberg’s structure we have ‘perceived’ and ‘named’ it, and are now in the process of bringing it into existence by our collective response. It is this step that is critical. We must be conscious that the way that we communicate symptoms and risk with each other and our patients has wider implications beyond the immediate clinical situation. Our human response to this new biological challenge is what will define this new disease for years to come.

Footnotes

  • This article was first posted on BJGP Life on 12 June 2020: https://bjgplife.com/2020/06/12/covid-19-and-the-creation-of-a-new-disease/

  • © British Journal of General Practice 2020

REFERENCES

  1. 1.↵
    1. Rosenberg C,
    2. Golden J
    Framing disease: studies in cultural historyNew Brunswick, NJRutgers University Press1992
  2. 2.↵
    1. Roberts M
    Coronavirus: NHS 111 has 1.7 million queries in 15 daysBBC20201Aprhttps://www.bbc.co.uk/news/health-52120804 (accessed 24 Jun 2020).
  3. 3.↵
    1. Greenhalgh T,
    2. Koh GCH,
    3. Car J
    Covid-19: a remote assessment in primary careBMJ2020368m1182
    OpenUrlFREE Full Text
  4. 4.↵
    1. News
    News Analysis. Covid-19 and thrombosis: what do we know about the risks and treatment?BMJ2020369m2058
    OpenUrlFREE Full Text
  5. 5.↵
    1. Comment
    Pulmonary fibrosis secondary to COVID-19: a call to arms?Lancet Respir Med2020DOI: https://doi.org/10.1016/S2213-2600(20)30222-8.
  6. 6.↵
    1. Roberts M
    Coronavirus alert: rare syndrome seen in UK childrenBBC202027Aprhttps://www.bbc.co.uk/news/health-52439005 (accessed 2 Jul 2020).
  7. 7.↵
    1. Philpotts E
    GPs alerted to ‘coronavirus-related’ condition emerging in childrenPulse202027Aprhttp://www.pulsetoday.co.uk/clinical/clinical-specialties/respiratory-/gps-alerted-to-coronavirus-related-condition-emerging-in-children/20040689.article (accessed 2 Jul 2020).
  8. 8.↵
    1. Riphagen H,
    2. Gomez X,
    3. Gonzalez-Martinez C,
    4. et al.
    Hyperinflammatory shock in children during COVID-19 pandemicLancet2020395102371607608https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31094-1/fulltext#%20 (accessed 2 Jul 2020).
    OpenUrlCrossRefPubMed
  9. 9.↵
    COVID-19 Prolonged Symptoms Survey — Analysis Report. What does COVID-19 recovery actually look like? An analysis of the prolonged COVID-19 symptoms survey by patient-led research team2020
  10. 10.↵
    1. Wu Z,
    2. McGoogan JM
    Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and PreventionJAMA2020doi:10.1001/jama.2020.2648
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Public Health England
    COVID-19: review of disparities in risks and outcomes2020
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 70 (697)
British Journal of General Practice
Vol. 70, Issue 697
August 2020
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 and the creation of a new disease
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
COVID-19 and the creation of a new disease
James Hibberd
British Journal of General Practice 2020; 70 (697): 401. DOI: 10.3399/bjgp20X712013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
COVID-19 and the creation of a new disease
James Hibberd
British Journal of General Practice 2020; 70 (697): 401. DOI: 10.3399/bjgp20X712013
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • COVID-19 IS A CHRONIC ILLNESS
    • DEFINING THIS NEW DISEASE
    • Footnotes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Depreciating assets: the female experience of health in the UK
  • Yonder: Autism, home visits, suicidal ideation, and young sudden cardiac death
  • Bullying during COVID-19: the impact on child and adolescent health
Show more Life & Times

Related Articles

Cited By...

Advertisement

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7679
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2021 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242